DB Biotech, a.s.
Slovakia SK-MF-000051838 Last updated 17 Sep 2026
- Devices
- 278
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Anti-PLAP (Placental Alkaline Phosphatase) Ref DB 047-0.1
Anti-Human SOX10 Ref DB 260-RTU-7
Anti-P504S (AMACR) Ref DB 208-1
DB Primary Antibody diluent Ref DB D - 125
Anti-CD15 Ref DB 211-0.1
Anti-S-100 Ref DB 055-0.2
Anti-CD163 Ref DB 045-0.2
Anti-PLAP (Placental Alkaline Phosphatase) Ref DB 047-0.5
DB Antigen retrieval solution, pH6, 10xconcentrated Ref DB Retris - 500
Anti-Cytokeratin 5/6 Ref DB 097-0.1
Anti-CD45 Ref DB 042-1
Anti-Napsin A Ref DB 262-0.5
Anti-EBV/LMP-1 Ref DB 061-0.2
Anti-Cytokeratin 7 Ref DB 051-RTU-7
Anti-Human SOX10 Ref DB 260-0.5
Anti-EBV/LMP-1 Ref DB 061-0.5
Anti-C4d complement Ref DB 107-RTU-7
Anti-Thyroglobulin Ref DB 259-0.2
Anti-Cytokeratin 19 Ref DB 103-RTU-7
Anti-Desmin Ref DB 148-0.5
Anti-Cytokeratin 17 Ref DB 101-RTU-15
Anti-EMA (CD227, Mucin-1) Ref DB 048-RTU-15
Anti-C3d complement Ref DB 106-RTU-7
Anti-Human SOX10 Ref DB 260-0.1
Anti-Human IgG Ref DB 173-RTU-7
Anti-CD45 Ref DB 042-0.1
Anti-p60 Ref DB 203-0.1
DB Antigen retrieval solution, pH6, 10xconcentrated Ref DB Retcit - 500
Anti-p53 Ref DB 026-0.2
Anti-CD23 Ref DB 135-RTU-7
Anti-iNOS Ref DB 003-IHC-RTU-7
Anti-TTF-1 Ref DB 089-0.2
Anti-CD23 Ref DB 135-RTU-15
Anti-CD3 Ref DB 082-RTU-7
Anti-Cytokeratin 16 Ref DB 100-0.1
Anti-Chromogranin A Ref DB 158-RTU-15
Anti-CD15 Ref DB 211-0.5
Anti-Napsin A Ref DB 262-RTU-15
Anti-Cytokeratin 8 Ref DB 098-0.1
Anti-Melan A Ref DB 050-RTU-7
Anti-Cytokeratin 18 Ref DB 102-0.1
Anti-Giardin α-1 Ref DB 319-RTU-15
Anti-Cytokeratin 17 Ref DB 101-0.1
Anti-BRAF Ref DB 159-RTU-7
Anti-Melanosome Ref DB 049-0.5
Anti-P504S (AMACR) Ref DB 208-0.5
Anti-p53 Ref DB 026-RTU-15
Anti-PSA (Prostate-specific antigen) Ref DB 254-0.2
Anti-Melan A Ref DB 050-0.5
Anti-CD3 Ref DB 082-0.2
Showing 51-100 of 278
About
Antibodies specially developed for IHC, WB and flow cytometry application. All rabbit clonal antibodies are developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DB Biotech scientific team.
What DB Biotech, a.s. makes
DB Biotech produces monoclonal antibodies targeting specific antigens for use in immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These include Anti-EBV/LMP-1, Anti-CD21, Anti-EGFR, Anti-Chromogranin A, Anti-Human Kappa Light Chain, Anti-EMA (CD227/Mucin-1), Anti-PSA, Anti-CD7, Anti-Human IgG, and Anti-CD8. The antibodies are designed for diagnostic applications in laboratory settings.
The company’s antibody portfolio is classified under EU medical device regulations as Class A and Class C, with devices registered in the EU’s eudamed database. DB Biotech is based in Slovakia.
Frequently asked questions
What types of medical devices does DB Biotech, a.s. manufacture?
DB Biotech, a.s. specializes in producing monoclonal antibodies designed for diagnostic use. These antibodies target specific antigens such as EBV/LMP-1, CD21, EGFR, Chromogranin A, and others, and are intended for applications like immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These products are developed to assist in laboratory-based diagnostic testing.
Where is DB Biotech, a.s. based?
DB Biotech, a.s. is headquartered in Slovakia. The company’s location is relevant for regulatory compliance, as it operates within the EU’s medical device framework, including registration in the eudamed database.
Which regulatory registries list DB Biotech’s devices?
DB Biotech’s medical devices are listed in the eudamed database, which is the official EU registry for medical devices. This registry ensures transparency and traceability of devices authorized under EU medical device regulations.
How are DB Biotech’s devices classified under EU regulations?
DB Biotech’s monoclonal antibodies fall under Class A and Class C classifications in the EU’s medical device regulatory framework. The classification depends on factors like the intended use, risk associated with the device, and the clinical significance of the diagnostic result. Class C devices are typically higher-risk diagnostic products, while Class A devices pose minimal risk.
Information
- Country
- Slovakia
- Address
- 80, Popradská, Košice, Slovakia
- Website
- www.dbbiotech.com
- [email protected]
- PRRC contact
- Martina Maďarová
- EUDAMED SRN
- SK-MF-000051838